Cannabis Schedule III in 2026: Where Rescheduling Stands, How It's Reshaping the Business, and What Comes Next
The biggest shift in federal cannabis policy in 50 years is unfolding now. Here's where Schedule III stands, how it's reshaping the business, and what the June 29 DEA hearing could change.
Addressing Marijuana Diversion: The Federal Government’s Next Steps Post-Rescheduling
As the federal government moves to reschedule marijuana from Schedule I to Schedule III, addressing marijuana diversion from legitimate channels to the illicit market becomes crucial, especially in states with lax regulatory oversight like California and Oklahoma.
A New Dawn for Medical Marijuana: DEA’s Rescheduling Proposal
The DEA's proposed rescheduling of marijuana from Schedule I to Schedule III marks a pivotal moment in cannabis regulation. This change could revolutionize medical research, healthcare, and the cannabis industry.
DEA Proposes Historic Shift in Marijuana Regulation
In a landmark move, the DEA proposes rescheduling marijuana from Schedule I to Schedule III, reflecting its medical benefits and lower abuse potential. This historic change could significantly impact the cannabis industry.